The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is produced by BioProcess Online and brought to you by Cytiva, formerly GE Healthcare Life Sciences.


Title Date published
RNA-Engineered Cell Therapy with Cartesian's Dr. Murat Kalayoglu 2021-06-07
Real-Time Clinical Analysis with Glympse Bio's Dr. Caroline Loew 2021-05-31
AAV & Lentivirus Gene Therapies with Sio Gene Therapeutics' Dr. Pavan Cheruvu 2021-05-24
Med Device Meets Biopharma with OncoSec's Dan O'Connor, J.D. 2021-05-17
Drug Development: From Bench To Bedside With Allan Shaw 2021-05-10
Digital Transformation In Cell Therapy with Organicell Drs. Mari Mitrani & Michael Bellio 2021-05-03
Biopharma Regulatory Requirements with bluebird bio's Scott Cleve 2021-04-26
Filling A Vaccine Void with Cue Biopharma's Dan Passeri, J.D. 2021-04-19
Supercharging An ADC Program With SOTIO CEO Dr. Radek Špíšek 2021-04-12
mAb Manufacturing with Rezolute Bio CEO Nevan Charles Elam, JD 2021-04-04
Cell Therapy Platforms With Precigen CEO Dr. Helen Sabzevari 2021-03-28
A CFO's Prescription For Biopharma Success With Allan Shaw 2021-03-21
A Biopharma Pivot with Compugen's Dr. Anat Cohen-Dayag 2021-03-15
Preparing For The Clinic With Amolyt Pharma CEO Dr. Thierry Abribat 2021-03-08
Pioneering Antiviral Conjugates with Cidara's Dr. Jeff Stein 2021-03-01
AI & The Human Genome With Dr. Dietrich Stephan 2021-02-22
The FDA's Progressive Appeal ft. Allan Shaw 2021-02-15
Celyad CEO Filippo Petti On In-House Allogeneic Cell Therapy Manufacturing 2021-02-08
Keeping Cell Therapy Clinicals On The Rails With Brian Culley 2021-02-01
Orchard Tx's Bobby Gaspar On Manufacturing Hematopoietic Stem Cells 2021-01-24

Comments about Business Of Biotech

comments powered by Disqus